Atox Bio

About:

Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.

Top Investors: OrbiMed, Adams Street Partners, Integra Holdings, SR One, Arix Bioscience

Description:

Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.It focuses on novel modulators of the immune response that target key multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases as well as ischemia/reperfusion injuries. The company was founded in 2003 and headquartered in HaMerkaz, Israel.

Total Funding Amount:

$58.4M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Ness Ziona, HaMerkaz, Israel

Founded Date:

2003-01-01

Contact Email:

dant(AT)atoxbio.com

Founders:

Gila Arad, Raymond Kaempfer

Number of Employees:

1-10

Last Funding Date:

2017-12-04

IPO Status:

Private

Industries: